Funding the Care AND Funding the Cure
In the race to lessen the impact of Alzheimer’s, we are focused on funding the care AND funding the cure, which is why we contribute to both UCLA and the Nantz National Alzheimer Center at Houston Methodist respectively. Houston Methodist was one of the clinical trial sites for aducanumab, the […]